Home 
Bratislava Medical Journal 2023 Bratislava Medical Journal Vol.124, No.5, p.363–367, 2023
Bratislava Medical Journal 2023 Bratislava Medical Journal Vol.124, No.5, p.363–367, 2023
Journal info
|
||||
Select Journal
Journals
Acta Virologica Bratislava Medical Journal Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.124, No.5, p.363–367, 2023 |
||
| Title: How can an immunologist influence the occurrence of secondary infections in breast cancer? Real‑life study | ||
| Author: Norbert LUKAN, Anna HAJDUKOVA, Peter KOLARCIK, Vladimir BELLA | ||
| Abstract: BACKGROUND: Clinical manifestation of secondary immunodeficiency is responsible for the decrease in lfe quality in cancer‑treated patients, which may result in administration delays, dose reductions, even in discontinuation of treatment. The main aim of presented study was to stress the possibility of influencing secondary infections with adjunctive immuno-regulatory medicament (AIRT). METHODS: The presented real-life retrospective study involved a cohort of 94 adult female patients aged from 30 to 87 years with mean age of 58.4 (SD = 11.37). The cohort was divided into two groups. One group (54 patients; 57.45 %) was treated by using the adjunctive immuno-regulatory medicaments and the other, control group (40 patients; 42.55 %), was without any immunological interventions in relation to secondary immunodeficiency. Patients in both groups were treated by standard oncotherapy. RESULTS: The results show that in patients who were sent for immunological consultation, double-digit values of mild secondary infection frequencies were revealed. When immunologists decided to add adjunctive immunomodulatory medicament, the occurrence of infection and consumption of antibiotics decreased. The decrease was significant in the second evaluated interval (6th – 12th month). CONCLUSIONS: Our results strongly advise regular or even preventive examination of cancer patients by immunologic specialist for the purpose of attenuating some negative consequences of applied anti-tumor therapy (Tab. 1, Fig. 4, Ref. 14). Text in PDF www.elis.sk |
||
| Keywords: secondary infection, breast cancer, real‑life study, clinical immunology, treatment | ||
| Published online: 27-Feb-2023 | ||
| Year: 2023, Volume: 124, Issue: 5 | Page From: 363, Page To: 367 | |
| doi:10.4149/BLL_2023_055 |
||
|
|
 download file |
|